Pliant Therapeutics Inc. said it saw positive interim results from a Phase 2a positron emission tomography imaging-based clinical trial of PLN-74809 in patients with idiopathic pulmonary fib..צפה במאמר
Pliant Therapeutics Inc. (NASDAQ:PLRX) traded at $19.16 at close of the session on Tuesday, September 07, made a downward move of -0.83% on its previous day’s price. Looking at the stock we..צפה במאמר
Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that..צפה במאמר
Pliant Therapeutics Inc. (NASDAQ:PLRX) has seen 1.07 million shares traded in the recent trading session. The company, currently valued at $699.77M, closed the recent trade at $21.17 per sha..צפה במאמר
Pliant Therapeutics reported positive data from a phase 2 trial with its experimental fibrosis therapy, PLN-74809, this morning. Data from four patients given the anti-fibrosis candidate sug..צפה במאמר
pliant הגייה עם משמעויות, מילים נרדפות, הפכים, תרגומים, משפטים ועוד